Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Mélanie Drolet(Centre hospitalier de l'Université Laval), Petra J. Woestenberg(Canadian Institutes of Health Research), Bo Yu(Harbin Medical University), Teresa M. Imburgia(Canadian Institutes of Health Research), Christian Munk(Canadian Institutes of Health Research), Marta Checchi(Public Health England), Bo T. Hansen(Canadian Institutes of Health Research), Bette Liu(Sydney Local Health District), Eric P. F. Chow(The University of Melbourne), Élodie Bénard(Centre hospitalier de l'Université Laval), Dorothy A. Machalek(Canadian Institutes of Health Research), Pam Sonnenberg(Canadian Institutes of Health Research), Nathalie Grün(Canadian Institutes of Health Research), Christian Dehlendorff(Canadian Institutes of Health Research), Marc Brisson(Centre hospitalier universitaire de Québec), Marc Steben(Université Laval), Julia W. Gargano(Canadian Institutes of Health Research), Marie‐Claude Boily(Imperial College London), Susanne K. Kjær(Copenhagen University Hospital), Lauri E. Markowitz(Centers for Disease Control and Prevention), Denton Callander(Canadian Institutes of Health Research), Christopher K. Fairley(Melbourne Sexual Health Centre), Clare Tanton(Canadian Institutes of Health Research), Julia Brotherton(Canadian Institutes of Health Research), Norma Pérez(Université Laval), Cosette M. Wheeler(University of New Mexico), Suzanne M. Garland(Royal Women's Hospital), Jeannie Oliphant(Canadian Institutes of Health Research), Eva Herweijer(Canadian Institutes of Health Research), Basil Donovan(UNSW Sydney), María Jesús Purriños-Hermida(Canadian Institutes of Health Research), Mari Nygård(Norwegian Institute of Public Health), Shelley L. Deeks(Canadian Institutes of Health Research), Linda M. Niccolai(Canadian Institutes of Health Research), Megan A. Smith(Canadian Institutes of Health Research), Vincenzo Baldo(University of Padua), Kimberley Kavanagh(Canadian Institutes of Health Research), Tina Dalianis(Karolinska University Hospital), Jessica A. Kahn(Albert Einstein College of Medicine), Gina Ogilvie(BC Centre for Disease Control), Silvia Cocchio(Canadian Institutes of Health Research), Pär Sparén(Karolinska Institutet), Paul Brassard(Jewish General Hospital), David Mesher(Cancer Research UK), Kevin G. Pollock(Canadian Institutes of Health Research), Hammad Ali(Canadian Institutes of Health Research), Erich V. Kliewer(Canadian Institutes of Health Research), Elaine W. Flagg(Canadian Institutes of Health Research), Christopher Harrison(Children's Mercy Hospital), Anna Söderlund‐Strand(Canadian Institutes of Health Research)
Cited by 1,334
Related Papers
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
|PsycEXTRA Dataset|2007|1.9k
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.
|PubMed|2015|1.1k
Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
|JNCI Journal of the National Cancer Institute|2013|997